UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of Earliest Event Reported): | May 5, 2016 |
OPKO Health, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| Delaware | 001-33528 | 75-2402409 |
|
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| 4400 Biscayne Blvd., Miami, Florida | 33137 | |
|
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
| Registrant’s telephone number, including area code: | (305) 575-4100 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 5, 2016, OPKO Health, Inc. (the “Company”) held its 2016 Annual Meeting of Stockholders (the “Annual Meeting”). Below is a summary of the proposals and corresponding vote.
1. All ten nominees were elected to the Board of Directors with each director receiving votes as follows:
| Election of Directors | For | Withheld | Broker Non-Vote | |||||||||
Phillip Frost, M.D. |
305,610,847 | 43,042,874 | 532,544 | |||||||||
Jane H. Hsiao, Ph.D. |
299,884,717 | 48,769,004 | 532,544 | |||||||||
Steven D. Rubin |
299,664,031 | 48,989,690 | 532,544 | |||||||||
Robert A. Baron |
340,613,140 | 8,040,581 | 532,544 | |||||||||
Thomas E. Beier |
330,574,123 | 18,079,598 | 532,544 | |||||||||
Dmitry Kolosov |
289,313,175 | 59,340,546 | 532,544 | |||||||||
Richard A. Lerner, M.D |
289,440,454 | 58,826,027 | 532,544 | |||||||||
John A. Paganelli |
330,466,740 | 18,186,981 | 532,544 | |||||||||
Richard C. Pfenniger, Jr. |
340,775,423 | 7,781,023 | 532,544 | |||||||||
Alice Lin-Tsing Yu, M.D., Ph.D. |
317,169,052 | 31,484,669 | 532,544 | |||||||||
| 2. | The stockholders voted to approve the Company’s 2016 Equity Incentive Plan as disclosed in the Company’s Proxy Statement for the Annual Meeting. The votes on this proposal were as follows: |
| For | Against | Abstain | ||||||
318,027,362
|
29,977,703 | 1,181,200 | ||||||
There were no broker non-votes for the proposal.
No other matters were considered or voted upon at the Annual Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| OPKO Health, Inc. | ||||
| May 6, 2016 | By: |
/s/Adam Logal
|
||
|
|
||||
| Name: Adam Logal | ||||
| Title: Senior Vice President-Chief Financial Officer | ||||